• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体育锻炼和饮食在非酒精性脂肪性肝病治疗中的作用。

The role of physical exercise and diet in the treatment of non-alcoholic fatty liver disease.

作者信息

Grad Simona, Vulturar Romana, Fărcaş Radu A, Dumitraşcu Dan L

机构信息

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Second Medical Department, Emergency County Clinical Hospital, Cluj-Napoca, Romania.

出版信息

Med Pharm Rep. 2021 Nov;94(Suppl No 3):S38-S42. doi: 10.15386/mpr-2517. Epub 2021 Nov 29.

DOI:10.15386/mpr-2517
PMID:38912401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11188024/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by an accumulation of hepatic fat, diagnosed histologically or radiologically (ultrasound), in the absence of a secondary cause of steatosis, especially alcohol consumption. Its prevalence is estimated to be approximately 25%. This high prevalence is correlated with the risk factors attributed to the metabolic syndrome. Non-alcoholic steatohepatitis (NASH) is a progressive form of NAFL and it can lead to end-stage liver disease in some patients. Once diagnosed, lifestyle changes must be initiated to lower hepatic fat accumulations in the liver. Physical exercise and diet play the most important role in achieving the desired weight loss goal.

摘要

非酒精性脂肪性肝病(NAFLD)的特征是肝脏脂肪堆积,通过组织学或放射学(超声)诊断,且不存在脂肪变性的继发原因,尤其是饮酒。据估计其患病率约为25%。这种高患病率与代谢综合征的危险因素相关。非酒精性脂肪性肝炎(NASH)是NAFL的一种进展形式,在某些患者中可导致终末期肝病。一旦确诊,必须开始改变生活方式以减少肝脏中的脂肪堆积。体育锻炼和饮食在实现理想的体重减轻目标方面起着最重要的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d718/11188024/b740a65acd11/cm-94-s38f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d718/11188024/3f90bebc2e8c/cm-94-s38f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d718/11188024/b740a65acd11/cm-94-s38f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d718/11188024/3f90bebc2e8c/cm-94-s38f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d718/11188024/b740a65acd11/cm-94-s38f2.jpg

相似文献

1
The role of physical exercise and diet in the treatment of non-alcoholic fatty liver disease.体育锻炼和饮食在非酒精性脂肪性肝病治疗中的作用。
Med Pharm Rep. 2021 Nov;94(Suppl No 3):S38-S42. doi: 10.15386/mpr-2517. Epub 2021 Nov 29.
2
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.非酒精性脂肪性肝病全谱的代谢特征
JHEP Rep. 2022 Mar 26;4(5):100477. doi: 10.1016/j.jhepr.2022.100477. eCollection 2022 May.
3
(C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle.(C)-美沙西汀呼气试验提供了与脂肪储存相关而非与生活方式相关的亚临床肝功能障碍的证据。
JHEP Rep. 2020 Nov 4;3(1):100203. doi: 10.1016/j.jhepr.2020.100203. eCollection 2021 Feb.
4
Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.严重肥胖症中的肝脂质组学重塑表现为脂肪变性,且不会随着非酒精性脂肪性肝炎而进展。
J Hepatol. 2021 Sep;75(3):524-535. doi: 10.1016/j.jhep.2021.04.013. Epub 2021 Apr 20.
5
Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的诊断与分类:当前概念与尚存挑战
Hepatol Res. 2015 Jan;45(1):20-8. doi: 10.1111/hepr.12333. Epub 2014 May 20.
6
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.瑞美替隆:一种口服的小分子、肝脏靶向、β 选择性甲状腺激素受体激动剂,用于治疗非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
touchREV Endocrinol. 2023 May;19(1):60-70. doi: 10.17925/EE.2023.19.1.60. Epub 2023 May 1.
7
Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.非酒精性脂肪性肝病与生活方式改变,重点关注体育活动。
Korean J Intern Med. 2018 Jan;33(1):64-74. doi: 10.3904/kjim.2017.343. Epub 2017 Dec 6.
8
Role of diet and nutritional management in non-alcoholic fatty liver disease.饮食和营养管理在非酒精性脂肪性肝病中的作用。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.
9
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
10
Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.线粒体基因多态性改变肝脏细胞能量代谢并加重饮食诱导的非酒精性脂肪性肝炎。
Mol Metab. 2016 Feb 2;5(4):283-295. doi: 10.1016/j.molmet.2016.01.010. eCollection 2016 Apr.

本文引用的文献

1
Treatments for NAFLD: State of Art.非酒精性脂肪性肝病的治疗:现状
Int J Mol Sci. 2021 Feb 26;22(5):2350. doi: 10.3390/ijms22052350.
2
Management of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的管理
BMJ. 2021 Jan 18;372:m4747. doi: 10.1136/bmj.m4747.
3
High-intensity interval training for health benefits and care of cardiac diseases - The key to an efficient exercise protocol.高强度间歇训练对健康的益处及心脏病护理——高效运动方案的关键
World J Cardiol. 2019 Jul 26;11(7):171-188. doi: 10.4330/wjc.v11.i7.171.
4
Mediterranean diet and health status: Active ingredients and pharmacological mechanisms.地中海饮食与健康状况:有效成分和药理机制。
Br J Pharmacol. 2020 Mar;177(6):1241-1257. doi: 10.1111/bph.14778. Epub 2019 Jul 25.
5
5. Lifestyle Management: .5. 生活方式管理: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S46-S60. doi: 10.2337/dc19-S005.
6
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.当前非酒精性脂肪性肝病管理指南:系统评价与比较分析。
World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.
7
Current Prevention and Treatment Options for NAFLD.非酒精性脂肪性肝病的当前防治选择。
Adv Exp Med Biol. 2018;1061:149-157. doi: 10.1007/978-981-10-8684-7_12.
8
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理:美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
9
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.《2017年亚太地区非酒精性脂肪性肝病工作组指南 - 第2部分:管理与特殊群体》
J Gastroenterol Hepatol. 2018 Jan;33(1):86-98. doi: 10.1111/jgh.13856.
10
Treatment of NAFLD with diet, physical activity and exercise.非酒精性脂肪性肝病的饮食、身体活动和运动治疗。
J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23.